跳至主要内容
临床试验/NCT05268549
NCT05268549Unknown不适用

Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter Trial

The Central Hospital of Lishui City0 个研究点目标入组 80 人开始时间: 2022年3月12日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
主要终点
The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

研究概览

简要总结

This study is a retrospective, multicenter clinical study. The main objective is to analyze the risk factors affecting the recurrence of colorectal cancer patients with liver metastases who received radiofrequency/microwave ablation. Finally, we will construct a recurrence risk prediction model based on the risk factors and validated the model.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age:older than 18 years;
  • Patients with a single tumor diameter ≤5cm, no more than 3 tumor nodules, and the largest tumor diameter ≤3cm;
  • Absence of vessel, bile duct and adjacent organ invasion and distant metastasis;
  • The primary tumor of colorectal cancer has been resected, the liver metastases cannot be resected or the patient is unwilling to undergo surgery (clinical or pathological confirmation);
  • Normal coagulation status and liver function child-pugh A or B;
  • Liver metastases have not received other antitumor therapy after radiofrequency/microwave therapy (before disease progression);
  • Routine laboratory tests were performed before the first RF/microwave treatment;
  • Follow up for more than 12 months;
  • Obtained free informed consent.

排除标准

  • Large tumor, or diffuse intrahepatic metastasis;
  • Accompanied by vascular tumor thrombus or invasion of adjacent organs;
  • The primary tumor of colorectal cancer has not been resected, with extrahepatic metastasis;
  • Uncorrectable coagulation dysfunction and severe blood abnormalities, those with severe bleeding tendency;
  • Intractable massive ascites, cachexia;
  • Active infection, especially inflammation of the biliary system;
  • Severe liver, kidney, heart, lung, brain and other major organ failure;
  • Patients with impaired consciousness or unable to cooperate with treatment;
  • Missing follow-up data.

结局指标

主要结局

The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

时间窗: Time from enrollment to disease recurrence, assessed up to 18 months

The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

次要结局

  • Patients with colorectal cancer with liver metastases (CRLM) developed new metastases after radiofrequency/microwave ablation,assessed up to 18 months(Time from enrollment to developed new metastases, assessed up to 18 months)

研究者

发起方
The Central Hospital of Lishui City
申办方类型
Other
责任方
Sponsor

相似试验